PAX2 and renal cell carcinoma: While the mechanism by which the binding of SMADs to the PAX2 promoter leads to transcriptional suppression in CC-RCC cells has not been elucidated, SMAD proteins have been shown to interact with, and are able to form transcriptionally inactive complexes with co-repressors in kidney cells [50].